Moreover, we found that 4-HNE reduction serves as a poor prognostic factor in HCC tissues and is detected in SMARCA4 knockdown cells in vitro; however, the current study lacks in vivo support. This evidence concerns the gene SMARCA4 and hepatocellular carcinoma.